Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the
2019 ◽
Vol 25
(12)
◽
pp. 2388-2397
◽
2012 ◽
Vol 18
(4)
◽
pp. 652-654
◽
2015 ◽
Vol 21
(2)
◽
pp. S279
2013 ◽
Vol 92
(8)
◽
pp. 1137-1139
◽
2011 ◽
Vol 29
(15_suppl)
◽
pp. 6527-6527
◽